(Q53129243)

11 May 2018

title

Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy. (English)

1 reference

11 May 2018

author name string

Hideaki Miyake

1

1 reference

11 May 2018

Mototsugu Muramaki

2

1 reference

11 May 2018

Junya Furukawa

3

1 reference

11 May 2018

Hirokazu Tanaka

4

1 reference

11 May 2018

Taka-aki Inoue

5

1 reference

11 May 2018

Masato Fujisawa

6

1 reference

11 May 2018

publication date

31 May 2012

1 reference

11 May 2018

published in

Urologic Oncology

1 reference

11 May 2018

volume

31

1 reference

11 May 2018

issue

8

1 reference

11 May 2018

page(s)

1511-1516

1 reference

11 May 2018

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

What are the outcomes of radical prostatectomy for high-risk prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

The relationship between preoperative prostate-specific antigen and biopsy Gleason sum in men undergoing radical retropubic prostatectomy: a novel assessment of traditional predictors of outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Prostate cancer progression after therapy of primary curative intent: a review of data from prostate-specific antigen era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Expression patterns of potential therapeutic targets in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Expression of potential molecular markers in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.001

10.1016/J.UROLONC.2012.05.001

7 January 2021

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018